Core Insights - The article emphasizes that cellular regeneration, rather than organ transplantation, is the key to extending human healthspan and lifespan [1][17][23] Scientific Contributions - European Wellness Biomedical Group (EWBG) published the Human Cytology Atlas, mapping over 400 distinct human cell types, and a peer-reviewed study on organ aging [1][9][27] - The Human Cytology Atlas serves as a reference for understanding cellular diversity and its implications for precision medicine [10][27] Aging Mechanisms - Different organs age at varying rates, which is crucial for developing targeted interventions [12][27] - The cardiovascular and immune systems decline early, while the liver and kidneys show staggered vulnerability [12] Future of Medicine - The future of medicine is seen in the transplantation of cells rather than organs, focusing on repairing and rejuvenating life at the cellular level [8][21][27] - Protocols for healthspan are being tested, emphasizing the importance of extending healthy years over mere longevity [19][20] Global Collaborations - Prof. Mike Chan's work includes collaborations with institutions in Baoding, Germany, and Switzerland, focusing on cell-based therapies and training programs for physicians [20][27] Vision for Longevity - The article presents a shift in the conversation around longevity from speculative immortality to a science-driven focus on healthspan, which relies on cellspan [23][18]

How long should we live. I know for a lot of you this question has never come across your mind because we don't think we can change how long we live. But what if we can.Would we even want to. What impact would this have on our world. Let's imagine two people, person A and person B.Person A is a woman in her 50s. She's taking a mix of some life extending drugs and hormone therapies such as vagiferm, estradorm, and limeocycline. These maintain her bone density, hormone levels, and even her skin.She's physical ...

Group 1 - The focus is on future-oriented and undervalued stocks and digital assets that are strategically positioned to benefit from long-term technological, societal, and monetary shifts [1] - The approach combines speculative foresight with disciplined fundamental analysis to uncover asymmetric opportunities across both emerging and established names [1] - Key themes covered include AI, digital currencies, space infrastructure, and longevity, utilizing valuation models like DCF, relative metrics, and macro context [1] Group 2 - The work is designed for long-term investors seeking early positioning with strong narrative and financial grounding [1]

[Musica] Ma come. Te ne vai da Berlino, te ne vai dove non c'è nessuno a Valencia. Quanti di voi quando hanno annunciato una scelta hanno ricevuto questo sguardo un po' interdetto.E lo capisco, avevo 30 anni, avevo un team di oltre 30 persone e budget milionari da spendere in marketing. Quindi lo capisco che per qualcuno poteva sembrare una follia, ma non per me. Per me era una ribellione.una ribellione alle colle alle 9:00 di sera, alle startup che bruciano soldi senza sostenibilità economica e che brucian ...

Dr. Eric Topol’s longevity work identified daily habits to follow in a study of “super agers” who are healthy at ages 85 and above."I am taking my own advice," says Dr. Topol, a 70-year-old cardiologist.He shares the tips that he follows: 🔗 https://t.co/rGyUI4FX7L https://t.co/rB8cSdP6Hu ...

Company Focus - Loyal 公司致力于延长犬类的寿命和提高其健康水平 [1] - Loyal 公司已从顶级投资者处筹集 1.35 亿美元资金 [1] Regulatory Outlook - Loyal 公司预计明年将获得 FDA 的首次有条件批准 [1]

I believe there is so much to like about Alphabet, as this company is involved in many very important businesses that are a daily part of life for billions of people around the planet, from our searchLong-time stock market investor focused on strategic buying opportunities with dividend and value stocks. This investment strategy has resulted in a near 5 star rating on Tipranks.com and over 9,000 followers on Seeking Alpha. Follow me on Twitter for my latest trading ideas: @Hawkinvest1Analyst’s Disclosure:I/ ...

Health & Longevity - The study focuses on "super agers," individuals who maintain good health at 85 years and older [1] - Dr Eric Topol, a 70-year-old cardiologist, shares daily habits for longevity [1] - Dr Topol is following his own advice [1]

Group 1 - Monster Beverage Corporation (NASDAQ: MNST) is rated as a hold due to a strong balance sheet and sales momentum heading into Q3, despite high analyst expectations for long-term growth [1] - The company is positioned to benefit from long-term technological, societal, and monetary shifts, focusing on future-oriented and undervalued stocks and digital assets [1] - The analysis emphasizes a blend of speculative foresight with disciplined fundamental analysis to uncover asymmetric opportunities across both emerging and established sectors [1] Group 2 - The themes covered include AI, digital currencies, space infrastructure, and longevity, with a focus on filtering innovation through valuation models like DCF and relative metrics [1] - The work is designed for long-term investors seeking early positioning with a strong narrative and financial grounding [1]

Core Viewpoint - Genflow Biosciences Plc has filed a patent examination request in China for its SIRT6 Variants aimed at treating Non-Alcoholic Steatohepatitis (NASH), highlighting its commitment to expanding its intellectual property portfolio in the longevity sector [1]. Group 1: Company Developments - Genflow is the only publicly listed longevity company in Europe, indicating its unique position in the market [1]. - The patent application focuses on proprietary variants of the SIRT6 gene, which are designed to address NASH, a severe liver disease with limited treatment options [1]. Group 2: Industry Context - Non-Alcoholic Steatohepatitis (NASH) is identified as a progressive liver disease, emphasizing the need for innovative treatment solutions in this area [1].